XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income $ 675 $ 1,496
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income taxes (137) (46)
Non-cash operating lease cost 37 32
Depreciation and amortization 49 61
Amortization of capitalized software development costs [1] 133 187
Share-based compensation expense [2] 199 194
Realized and unrealized gain on equity investment (4) (72)
Other (23) 4
Changes in operating assets and liabilities, net of effect of business acquisitions:    
Accounts receivable, net 394 369
Software development (290) (189)
Other assets 61 20
Deferred revenues (268) (611)
Accounts payable (87) (80)
Accrued expenses and other liabilities 101 (133)
Net cash provided by operating activities 840 1,232
Cash flows from investing activities:    
Proceeds from maturities of available-for-sale investments 22 44
Proceeds from sale of available-for-sale investments 20 0
Purchases of available-for-sale investments (109) (203)
Acquisition of business, net of cash acquired (Note 4) (135) 0
Capital expenditures (52) (36)
Other investing activities 1 21
Net cash used in investing activities (253) (174)
Cash flows from financing activities:    
Proceeds from issuance of common stock to employees 37 67
Tax payment related to net share settlements on restricted stock units (137) (173)
Dividends paid (367) (365)
Net cash used in financing activities (467) (471)
Effect of foreign exchange rate changes on cash and cash equivalents (48) (16)
Net increase in cash and cash equivalents and restricted cash 72 571
Cash and cash equivalents and restricted cash at beginning of period 10,438 8,652
Cash and cash equivalents and restricted cash at end of period $ 10,510 $ 9,223
[1] Excludes deferral and amortization of share-based compensation expense, including liability awards accounted for under ASC 718.
[2] Includes the net effects of capitalization, deferral, and amortization of share-based compensation expense, including liability awards accounted for under ASC 718.